Loading…
.png%3Fwidth%3D800&w=640&q=75)
vitiligo
hypersensitivity reaction type II disease that causes depigmentation of skin patches resulting from loss of function or death of melanocytes
Details
- Instance of
- type of disease
- Subclass of
- autoimmune skin disease
- Said to be the same as
- Pes
- described by source
- Great Soviet Encyclopedia (1926–1947), Meyers Konversations-Lexikon, 4th edition (1885–1890)
- drug or therapy used for treatment
- monobenzone, methoxsalen, trioxsalen
- genetic association
- LPP, BACH2, CASP7, IKZF4, TICAM1, ZMIZ1, RERE, monophenol monooxygenase, GZMB, UBASH3A, C1QTNF6, SMOC2
- health specialty
- dermatology
- ICD-9-CM
- 709.01
- studied by
- biology of colour
- symptoms and signs
- depigmentation
- topic's main category
- Category:Vitiligo
Connected on Wikidata
Subject of
- World Vitiligo Day
- Examination Of Vitiligo Skin Samples Before and After UVB Treatment
- Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model
- Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
- Cutaneous JAK in Vitiligo and Acne Vulgaris.
- Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo
- Evaluation of Scanoskin for the Assessment of Vitiligo
- A Study of Ruxolitinib Phosphate Cream in Subjects With Vitiligo
- Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo
- Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
- Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo
Nothing in the MetaHistoryBook collection references this item yet.